loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Information, Expiry & Status of FDA Orange Book Patents covering Rifaximin

    Client Email Product
    Menu

    Rifaximin

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Forms

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 SALIX PHARMS (54)

    filter

    01 7045620 (2)

    02 7612199 (2)

    03 7902206 (2)

    04 7906542 (2)

    05 7915275 (2)

    06 7928115 (1)

    07 8158644 (2)

    08 8158781 (2)

    09 8193196 (3)

    10 8309569 (2)

    11 8518949 (2)

    12 8642573 (1)

    13 8741904 (4)

    14 8829017 (1)

    15 8835452 (2)

    16 8853231 (2)

    17 8946252 (1)

    18 8969398 (1)

    19 9271968 (2)

    20 9421195 (1)

    21 9629828 (1)

    22 10314828 (1)

    23 10335397 (1)

    24 10456384 (2)

    25 10703763 (6)

    26 10709694 (1)

    27 10765667 (2)

    28 11564912 (2)

    29 11779571 (1)

    filter

    01 Y (19)

    02 Blank (35)

    filter

    01 Y (20)

    02 Blank (34)

    filter

    01 2024-06-19 (14)

    02 2025-02-23 (2)

    03 2025-06-01 (2)

    04 2026-02-27 (14)

    05 2027-09-02 (3)

    06 2029-02-26 (7)

    07 2029-07-18 (2)

    08 2029-07-24 (8)

    09 2029-10-02 (2)

    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    SALIX PHARMS

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RIFAXIMIN

    PDF Supplier PDF
    URL Supplier Web Content
    8741904
    Y
    2026-02-27
    U-1526
    21361
    THE TREATMENT OF PATIENTS WITH TRAVELERS' DIARRHEA (TD) OR THE REDUCTION IN RISK OF OVERT HEPATIC ENCEPHALOPATHY (HE) RECURRENCE
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    SALIX PHARMS

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RIFAXIMIN

    PDF Supplier PDF
    URL Supplier Web Content
    7928115
    2029-07-24
    U-1121
    21361
    METHOD OF TREATING TRAVELERS' DIARRHEA
    1
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    SALIX PHARMS

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RIFAXIMIN

    PDF Supplier PDF
    URL Supplier Web Content
    7915275
    2025-02-23
    U-1708
    21361
    TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN ADULTS.
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    SALIX PHARMS

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RIFAXIMIN

    PDF Supplier PDF
    URL Supplier Web Content
    7915275
    2025-02-23
    U-1707
    21361
    TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN ADULTS AND SYMPTOMS THEREOF.
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    SALIX PHARMS

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RIFAXIMIN

    PDF Supplier PDF
    URL Supplier Web Content
    8193196
    Y
    Y
    2027-09-02
    U-1707
    21361
    TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN ADULTS AND SYMPTOMS THEREOF.
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    SALIX PHARMS

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RIFAXIMIN

    PDF Supplier PDF
    URL Supplier Web Content
    8193196
    Y
    Y
    2027-09-02
    U-1708
    21361
    TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN ADULTS.
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    SALIX PHARMS

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RIFAXIMIN

    PDF Supplier PDF
    URL Supplier Web Content
    8309569
    2029-07-18
    U-1708
    21361
    TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN ADULTS.
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    SALIX PHARMS

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RIFAXIMIN

    PDF Supplier PDF
    URL Supplier Web Content
    8309569
    2029-07-18
    U-1707
    21361
    TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN ADULTS AND SYMPTOMS THEREOF.
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    SALIX PHARMS

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RIFAXIMIN

    PDF Supplier PDF
    URL Supplier Web Content
    8741904
    Y
    2026-02-27
    U-1526
    21361
    THE TREATMENT OF PATIENTS WITH TRAVELERS' DIARRHEA (TD) OR THE REDUCTION IN RISK OF OVERT HEPATIC ENCEPHALOPATHY (HE) RECURRENCE
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    SALIX PHARMS

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RIFAXIMIN

    PDF Supplier PDF
    URL Supplier Web Content
    8741904
    Y
    2026-02-27
    U-1708
    21361
    TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN ADULTS.
    2
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY